Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Uterine bleeding
Age: Adult
Dose: Oral – 5-10 mg
Frequency: once daily
Duration: 5-10 days
Note: Beginning day 16 or 21 of the menstrual cycle; withdrawal bleeding may be expected within 3 to 7 days after discontinuing medroxyprogesterone.
Indication: Amenorrhea, secondary
Age: Adult
Dose: Oral – 5-10 mg
Frequency: once daily
Duration: 5-10 days
Note: May be started at any time; withdrawal bleeding may be expected within 3-7 days after discontinuing medroxyprogesterone.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: NO_HEADER – No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • Can be taken with or without food
  • Take with meals if upset stomach
Side Effect

Drug Interaction

Drug NameRisk Factors
Aminoglutethimide, enzyme-inducing drugs (e.g. carbamazepine, griseofulvin, phenobarbital, rifampicin, phenytoin)
May reduce plasma concentrations leading to reduced efficacy

Disease Interaction

Disease NameRisk Factors
Thromboembolic disorders
Risk of blood clots
Hormone-dependent carcinoma
May stimulate tumor growth

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.